opioids

News

Insys execs face jail for illegal US prescription conspiracy

The founder of Insys Therapeutics, John Kapoor, and four colleagues face jail after a US court convicted them of a racketeering conspiracy where doctors were illegally induced to prescribe

Partner Content

Partner Content

Registration is closing soon for SMi’s 22nd Annual Pain Ther...

Registrations Closing Soon

Events

Partner Content

SMi’s 22nd Annual Pain Therapeutics Conference

Pain Therapeutics Conference

News

Tablets on dollar bills (treatment, addiction, aging - concept). Vintage effect.

Collegium agrees $604m buyout of pain specialist BDSI

Collegium Pharma has expanded its pain franchise though a deal to acquire BioDelivery Sciences International (BDSI), which has three FDA-approved drugs and a new migraine therapy due to lau

News

Digital therapeutic cuts opioid use disorder care costs, say...

A real-world study of digital therapeutic (DTx) for opioid use disorder has found that patient show used it had 46% fewer hospital stays than a control group, saving more than $2,700 over a

News

Indivior pays $300m to settle Suboxone marketing allegations

Indivior has paid out $300 million to resolve civil claims from US states after it was last year found guilty against criminal charges of improper marketing of the opioid addiction drug Sub

Insys execs face jail for illegal US prescription conspiracy

Registration is closing soon for SMi’s 22nd Annual Pain Ther...

SMi’s 22nd Annual Pain Therapeutics Conference

Collegium agrees $604m buyout of pain specialist BDSI

Digital therapeutic cuts opioid use disorder care costs, say...

Indivior pays $300m to settle Suboxone marketing allegations

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

opioids

Editor's Picks